Abstract
We read the article by Wong et al with interest and congratulate the authors for their addition to the literature regarding de novo donor specific antihuman leukocyte antigen antibodies (dnDSA) following heart transplantation.1 DSA have been shown to be detrimental following heart transplantation, leading to increased cellular rejection, cardiac allograft vasculopathy, antibody mediated rejection (AMR), and mortality.2–4 We recently reported our experience with a prospective cohort of …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
